Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
M5181 - a novel vitamin D3 analogue - is currently under development for the treatment of
plaque psoriasis and is being developed as a topical ointment formulation (M518101)
Clinical and non-clinical studies indicate that M5181 is an effective treatment for plaque
psoriasis.
Based on the results of previous phase II trials the phase III trial has been designed to
evaluate efficacy and safety of an 8-week treatment period with 50 μg/g M518101 in a larger
population of patients with stable plaque psoriasis.
Phase:
Phase 3
Details
Lead Sponsor:
Maruho Europe Limited
Collaborator:
Maruho Co., Ltd.
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins